Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel method for (R)/(S)-6,6'-dihydroxy-5,5'-bisquinoline using CuCl2 oxidation and crystallization resolution, offering high purity and scalable production for pharma intermediates.
Novel oxaspiro diphosphine ligand synthesis enables >99% ee hydrogenation. Reliable supplier for high-purity chiral intermediates.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Patent CN110878104A reveals a safer two-step route for chiral phosphine ligands. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN105859800B details a high-yield synthesis of chiral ferrocene P,P ligands. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover a novel preparation method for metal NHC complexes via patent CN101402644B, offering cost-effective catalytic solutions and scalable manufacturing for pharmaceutical intermediates.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel preparation of cis-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid via asymmetric addition. Enhances catalytic efficiency and reduces manufacturing costs for high-purity intermediates.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN113292598A discloses a Rh(III)-catalyzed enantioselective synthesis of axial chiral biaryl compounds with P-stereocenters, offering significant supply chain advantages.
Patent CN119874773B reveals advanced ligand enhancing conversion stability. Delivers supply chain reliability and cost optimization for global chemical manufacturing.
Novel iridium-catalyzed C-H bond boronation method offers high selectivity and yield for pharmaceutical intermediate manufacturing without strong acids.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN109293700B discloses a novel chiral ligand enabling ultra-low nickel loading for enantioselective cyclization, offering significant cost and efficiency advantages.
Novel Rh-catalyzed route for 1-naphthol phosphine oxide ligands. High yield, mild conditions. Cost-effective manufacturing for pharma intermediates.